Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc.verified

TPST

Price:

$1.26

Market Cap:

$5.60M

Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highlights two key therapeutic candidates: TPST-1495, a compound functioning as a dual inhibitor of EP2 and EP4 receptors (which are implicated in prostaglandin E2 signaling), currently undergoing initial human trials for solid tumor indications. The second candidate, TPST-1120, is a targeted blocker of peroxisome proliferator-activated receptor alpha, also progressing through Phase 1 studies for solid tumors. Beyond these clinical assets, Tempest is exploring TREX-1, a pivotal cellular enzyme known for...[Read more]

Industry

Biotechnology

IPO Date

2012-11-12

Stock Exchange

NASDAQ

Ticker

TPST

The Current Ratio as of June 2026 (TTM) for Tempest Therapeutics, Inc. (TPST) is 0.74

According to Tempest Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.74. This represents a change of -61.36% compared to the average of 1.91 of the last 4 quarters.

Tempest Therapeutics, Inc. (TPST) Historical Current Ratio (quarterly & annually)

How has TPST Current Ratio performed in the past?

The mean historical Current Ratio of Tempest Therapeutics, Inc. over the last ten years is 5.09. The current 0.74 Current Ratio has changed 1.35% with respect to the historical average. Over the past ten years (40 quarters), TPST's Current Ratio was at its highest in in the June 2016 quarter at 13.98. The Current Ratio was at its lowest in in the March 2026 quarter at 0.74.

Quarterly (TTM)
Annual

Average

5.09

Median

4.68

Minimum

2.21

Maximum

8.82

Tempest Therapeutics, Inc. (TPST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tempest Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 76.13%

Maximum Annual Current Ratio = 8.82

Minimum Annual Increase = -48.39%

Minimum Annual Current Ratio = 2.21

Quarterly (TTM)
Annual
YearCurrent RatioChange
20252.5012.73%
20242.21-48.39%
20234.29-5.28%
20224.5331.49%
20213.44-44.03%
20206.158.30%
20195.68-33.14%
20188.5076.13%
20174.82-45.27%
20168.82-23.68%

Tempest Therapeutics, Inc. (TPST) Average Current Ratio

How has TPST Current Ratio performed in the past?

The current Current Ratio of Tempest Therapeutics, Inc. (TPST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.00

5-year avg

3.39

10-year avg

5.09

Tempest Therapeutics, Inc. (TPST) Current Ratio vs. Peers

How is TPST’s Current Ratio compared to its peers?

Tempest Therapeutics, Inc.’s Current Ratio is less than OnKure Therapeutics, Inc. (13.78), less than Kezar Life Sciences, Inc. (24.46), less than FibroGen, Inc. (3.61), less than Aligos Therapeutics, Inc. (2.56), less than Mersana Therapeutics, Inc. (1.39), less than Xilio Therapeutics, Inc. (3.59), less than PDS Biotechnology Corporation (2.26), less than Actinium Pharmaceuticals, Inc. (5.89), less than Barinthus Biotherapeutics plc (6.05), less than INmune Bio, Inc. (4.24),

Build a custom stock screener for Tempest Therapeutics, Inc. (TPST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tempest Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tempest Therapeutics, Inc. (TPST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tempest Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Tempest Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Tempest Therapeutics, Inc. (TPST)?

What is the highest Current Ratio for Tempest Therapeutics, Inc. (TPST)?

What is the 3-year average Current Ratio for Tempest Therapeutics, Inc. (TPST)?

What is the 5-year average Current Ratio for Tempest Therapeutics, Inc. (TPST)?

How does the current Current Ratio for Tempest Therapeutics, Inc. (TPST) compare to its historical average?